Related Experiment Video
Updated: Jul 22, 2025

13:19
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
16.6K
Locus specific endogenous retroviral expression associated with Alzheimer's disease
Tyson Dawson1,2, Uzma Rentia1, Jessie Sanford3
1Computational Biology Institute, The George Washington University, Washington, DC, United States.
Frontiers in Aging Neuroscience
|July 24, 2023
Summary
Human endogenous retroviruses (HERVs) are linked to Alzheimer's disease. Dysregulated HERV expression and localization patterns in Alzheimer's patients may drive pathogenic gene expression, offering new insights into disease mechanisms.
Area of Science:
- Genomics
- Neuroscience
- Molecular Biology
Background:
- Human endogenous retroviruses (HERVs) are ancient retroviral remnants integrated into the human genome.
- Aberrant HERV expression is implicated in various diseases, including neurological disorders.
- The role of HERVs in Alzheimer's disease (AD) pathogenesis remains incompletely understood.
Purpose of the Study:
- To investigate the expression patterns of HERVs in Alzheimer's disease patients.
- To explore the correlation between HERV expression and gene expression in AD.
- To determine the genomic localization of differentially expressed HERVs in relation to disease-associated genes.
Main Methods:
- Combined two public and one novel RNA-Seq datasets from 103 AD patients and 45 healthy controls.
- Utilized the 'telescope' tool for HERV quantification and gene expression analysis.
- Identified differentially expressed genes and HERVs, and analyzed their genomic proximity.
Main Results:
- Identified significant differences in gene and HERV expression between AD patients and controls.
- Discovered numerous differentially expressed HERVs across the genome, with many belonging to the HERV-K superfamily.
- Found correlations between specific HERVs and dysregulated genes involved in AD pathways, often located in close physical proximity.
Conclusions:
- Dysregulated expression of HERVs is a feature of Alzheimer's disease.
- The genomic localization of these HERVs suggests a mechanism by which they may influence pathogenic gene expression in AD.
- These findings highlight HERVs as potential contributors to Alzheimer's disease pathology.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
525
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
525
Non-LTR Retrotransposons
11.6K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.6K
Alzheimer's Disease: Treatment
219
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
219
LTR Retrotransposons
17.6K
LTR retrotransposons are class I transposable elements with long terminal repeats flanking an internal coding region. These elements are less abundant in mammals compared to other class I transposable elements. About 8 percent of human genomic DNA comprises LTR retrotransposons. Some of the common examples of LTR retrotransposons are Ty elements in yeast and Copia elements in Drosophila.
The internal coding region of LTR retrotransposons and their mechanism of transposition closely resembles a...
The internal coding region of LTR retrotransposons and their mechanism of transposition closely resembles a...
17.6K

